Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Total-Current-Liabilities" stands at 1.11 Trillion Japanese Yens as of 06/30/2025.
As of the end of Astellas Pharma Inc.'s first quarter, the item "Total Current Liabilities" stands at 1.11 Trillion JPY. This represents an increase of 4.36 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -19.35 percent compared to the value the year prior.
The 1 year change in percent is -19.35.
The 3 year change in percent is 49.61.
The 5 year change in percent is 71.06.
The 10 year change in percent is 183.20.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Current Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Current Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Current Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Current Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Current Liabilities | 280,205,508,085.11 |